• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

海洋海绵中的生物活性甾体和三萜类化合物:存在和药理意义。

Bioactive sesterterpenes and triterpenes from marine sponges: occurrence and pharmacological significance.

机构信息

Institute of Pharmaceutical Biology and Biotechnology, Heinrich-Heine University, Duesseldorf, Germany.

出版信息

Mar Drugs. 2010 Feb 23;8(2):313-46. doi: 10.3390/md8020313.

DOI:10.3390/md8020313
PMID:20390108
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2852841/
Abstract

Marine ecosystems (>70% of the planet's surface) comprise a continuous resource of immeasurable biological activities and immense chemical entities. This diversity has provided a unique source of chemical compounds with potential bioactivities that could lead to potential new drug candidates. Many marine-living organisms are soft bodied and/or sessile. Consequently, they have developed toxic secondary metabolites or obtained them from microorganisms to defend themselves against predators [1]. For the last 30-40 years, marine invertebrates have been an attractive research topic for scientists all over the world. A relatively small number of marine plants, animals and microbes have yielded more than 15,000 natural products including numerous compounds with potential pharmaceutical potential. Some of these have already been launched on the pharmaceutical market such as Prialt (ziconotide; potent analgesic) and Yondelis (trabectedin or ET-743; antitumor) while others have entered clinical trials, e.g., alpidin and kahalalide F. Amongst the vast array of marine natural products, the terpenoids are one of the more commonly reported and discovered to date. Sesterterpenoids (C(25)) and triterpenoids (C(30)) are of frequent occurrence, particularly in marine sponges, and they show prominent bioactivities. In this review, we survey sesterterpenoids and triterpenoids obtained from marine sponges and highlight their bioactivities.

摘要

海洋生态系统(占地球表面的 70%以上)包含了无数生物活动和大量化学物质的连续资源。这种多样性为具有潜在生物活性的化合物提供了独特的来源,这些化合物可能成为潜在的新药候选物。许多海洋生物是软躯体生物和/或固着生物。因此,它们产生了有毒的次生代谢物,或从微生物中获得这些物质,以抵御捕食者[1]。在过去的 30-40 年中,海洋无脊椎动物一直是全世界科学家的热门研究课题。为数相对较少的海洋植物、动物和微生物已经产生了超过 15000 种天然产物,其中包括许多具有潜在药用潜力的化合物。其中一些已经在药物市场上推出,如 Prialt(佐米曲坦;强效镇痛药)和 Yondelis(埃博霉素或 ET-743;抗肿瘤药),而其他一些已经进入临床试验,如 alpidin 和 kahalalide F。在大量的海洋天然产物中,萜类化合物是迄今为止报道和发现较多的一类。倍半萜(C(25)) 和三萜(C(30)) 是常见的萜类化合物,尤其是在海洋海绵中,它们表现出显著的生物活性。在这篇综述中,我们调查了从海洋海绵中获得的倍半萜和三萜,并强调了它们的生物活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/ecc31103ed39/marinedrugs-08-00313f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/0d2951225ba4/marinedrugs-08-00313f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/c29a4b5fe87f/marinedrugs-08-00313f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/c6678f28e626/marinedrugs-08-00313f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/6cc059627f0e/marinedrugs-08-00313f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/2277faa4f909/marinedrugs-08-00313f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/48f3c07083b7/marinedrugs-08-00313f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/4b9ee6ffef27/marinedrugs-08-00313f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/965cbb8dcf4f/marinedrugs-08-00313f11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/8f0170552def/marinedrugs-08-00313f12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/0f1f6a40e378/marinedrugs-08-00313f13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/dcec78e71367/marinedrugs-08-00313f14.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/c3dccb15f47f/marinedrugs-08-00313f15.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/54fbf2154e6e/marinedrugs-08-00313f16.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/cfd7a4e36e79/marinedrugs-08-00313f17.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/ff648cf26b2c/marinedrugs-08-00313f18.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/591c181a22e7/marinedrugs-08-00313f19.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/5dd90d0ebe87/marinedrugs-08-00313f20.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/d5ed2cd82460/marinedrugs-08-00313f21.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/46ac2ad8c8d9/marinedrugs-08-00313f22.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/889a94fb9509/marinedrugs-08-00313f23.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/1cb78d9355cd/marinedrugs-08-00313f24.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/70735382bbb2/marinedrugs-08-00313f25.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/563604b1a742/marinedrugs-08-00313f26.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/919cba031f3b/marinedrugs-08-00313f27.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/e601f664cd4f/marinedrugs-08-00313f28.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/01bb3fa806d3/marinedrugs-08-00313f29.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/172339a3bfd0/marinedrugs-08-00313f30.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/7db5d432ce16/marinedrugs-08-00313f31.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/db7ea92bc4ca/marinedrugs-08-00313f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/ff4cac376d45/marinedrugs-08-00313f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/ecc31103ed39/marinedrugs-08-00313f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/0d2951225ba4/marinedrugs-08-00313f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/c29a4b5fe87f/marinedrugs-08-00313f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/c6678f28e626/marinedrugs-08-00313f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/6cc059627f0e/marinedrugs-08-00313f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/2277faa4f909/marinedrugs-08-00313f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/48f3c07083b7/marinedrugs-08-00313f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/4b9ee6ffef27/marinedrugs-08-00313f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/965cbb8dcf4f/marinedrugs-08-00313f11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/8f0170552def/marinedrugs-08-00313f12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/0f1f6a40e378/marinedrugs-08-00313f13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/dcec78e71367/marinedrugs-08-00313f14.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/c3dccb15f47f/marinedrugs-08-00313f15.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/54fbf2154e6e/marinedrugs-08-00313f16.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/cfd7a4e36e79/marinedrugs-08-00313f17.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/ff648cf26b2c/marinedrugs-08-00313f18.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/591c181a22e7/marinedrugs-08-00313f19.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/5dd90d0ebe87/marinedrugs-08-00313f20.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/d5ed2cd82460/marinedrugs-08-00313f21.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/46ac2ad8c8d9/marinedrugs-08-00313f22.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/889a94fb9509/marinedrugs-08-00313f23.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/1cb78d9355cd/marinedrugs-08-00313f24.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/70735382bbb2/marinedrugs-08-00313f25.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/563604b1a742/marinedrugs-08-00313f26.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/919cba031f3b/marinedrugs-08-00313f27.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/e601f664cd4f/marinedrugs-08-00313f28.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/01bb3fa806d3/marinedrugs-08-00313f29.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/172339a3bfd0/marinedrugs-08-00313f30.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/7db5d432ce16/marinedrugs-08-00313f31.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/db7ea92bc4ca/marinedrugs-08-00313f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/ff4cac376d45/marinedrugs-08-00313f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc5c/2852841/ecc31103ed39/marinedrugs-08-00313f3.jpg

相似文献

1
Bioactive sesterterpenes and triterpenes from marine sponges: occurrence and pharmacological significance.海洋海绵中的生物活性甾体和三萜类化合物:存在和药理意义。
Mar Drugs. 2010 Feb 23;8(2):313-46. doi: 10.3390/md8020313.
2
Additional sesterterpenes and a nortriterpene saponin from the sponge Clathria gombawuiensis.来自贡巴威氏网纹海绵的其他倍半萜和一种降三萜皂苷。
J Nat Prod. 2015 Feb 27;78(2):218-24. doi: 10.1021/np500753q. Epub 2015 Jan 29.
3
Protein phosphatase inhibitors isolated from Spongia irregularis collected in Papua New Guinea.从收集于巴布亚新几内亚的不规则海绵中分离出的蛋白质磷酸酶抑制剂。
J Nat Prod. 2007 Nov;70(11):1812-5. doi: 10.1021/np0702887. Epub 2007 Nov 3.
4
Cytotoxic scalarane-type sesterterpenes from the Saudi Red Sea sponge Hyrtios erectus.来自沙特红海海绵直立扁海绵的细胞毒性梯形烷型倍半萜烯。
J Asian Nat Prod Res. 2016 Jun;18(6):611-7. doi: 10.1080/10286020.2015.1115019. Epub 2015 Dec 2.
5
Bioactive Scalarane-Type Sesterterpenoids from Marine Sources.海洋源生物活性萜类倍半萜。
Chem Biodivers. 2022 May;19(5):e202200049. doi: 10.1002/cbdv.202200049. Epub 2022 Apr 28.
6
Bioactive Natural Products of Marine Sponges from the Genus Hyrtios.来自Hyrtios属的海洋海绵的生物活性天然产物。
Molecules. 2017 May 11;22(5):781. doi: 10.3390/molecules22050781.
7
Bioactive terpenes from Spongia officinalis.从药用海绵中提取的生物活性萜类化合物。
J Nat Prod. 2011 May 27;74(5):1241-7. doi: 10.1021/np200226u. Epub 2011 May 6.
8
Sulawesins A-C, Furanosesterterpene Tetronic Acids That Inhibit USP7, from a Psammocinia sp. Marine Sponge.苏拉维辛A - C,来自一种沙栖海绵属海洋海绵的抑制USP7的呋喃酯萜四酮酸。
J Nat Prod. 2017 Jul 28;80(7):2045-2050. doi: 10.1021/acs.jnatprod.7b00184. Epub 2017 Jun 16.
9
A new family of sesterterpenoids isolated around the Pacific Rim.一种新型的甾族倍半萜在环太平洋地区被分离出来。
Nat Prod Rep. 2018 Mar 21;35(3):210-219. doi: 10.1039/C7NP00049A.
10
Manoalide-related Sesterterpene from the Marine Sponge Luffariella variabilis.来自海洋海绵可变硬皮海绵的与 manoalide 相关的倍半萜。
Nat Prod Commun. 2015 Jun;10(6):863-4.

引用本文的文献

1
Network pharmacology and molecular dynamics simulation reveal antineoplastic potential of Antarctic sponge-derived suberitenones.网络药理学和分子动力学模拟揭示南极海绵衍生的软海绵酮的抗肿瘤潜力。
Front Chem. 2025 May 27;13:1545834. doi: 10.3389/fchem.2025.1545834. eCollection 2025.
2
Diverse lifestyles and adaptive evolution of uncultured UBA5794 actinobacteria, a sister order of "Candidatus actinomarinales".未培养的UBA5794放线菌的多样生活方式和适应性进化,“候选放线菌目”的姐妹目
Environ Microbiome. 2025 Apr 19;20(1):39. doi: 10.1186/s40793-025-00701-w.
3
Exploring the Metabolic Profiling and Anticancer Activities of Red Sea Sponges and against Human Breast Cancer Cells: A Comparative Study.

本文引用的文献

1
Hemisynthesis of two marine cheilanthane sesterterpenes from (-)-sclareol: first enantioselective synthesis of petrosaspongiolide R.由(-)-香紫苏醇半合成两种海洋唇形烷倍半萜:岩海绵内酯R的首次对映选择性合成。
Nat Prod Res. 2009;23(3):256-63. doi: 10.1080/14786410801997075.
2
24-O-ethylmanoalide, a manoalide-related sesterterpene from the marine sponge Luffariella cf. variabilis.24-O-乙基软海绵素,一种来自海洋海绵类似可变粗皮海绵的与软海绵素相关的倍半萜烯。
Molecules. 2008 Dec 15;13(12):3184-91. doi: 10.3390/molecules13123184.
3
The binding mode of petrosaspongiolide M to the human group IIA phospholipase A(2): exploring the role of covalent and noncovalent interactions in the inhibition process.
红海海绵的代谢谱分析及其对人乳腺癌细胞的抗癌活性研究:一项比较研究
ACS Omega. 2025 Feb 25;10(9):9402-9425. doi: 10.1021/acsomega.4c10202. eCollection 2025 Mar 11.
4
A Novel Sesterterpenoid, Petrosaspongin and γ-Lactone Sesterterpenoids with Leishmanicidal Activity from Okinawan Marine Invertebrates.一种来自冲绳海洋无脊椎动物的具有抗利什曼原虫活性的新型倍半萜、岩海绵内酯和γ-内酯倍半萜。
Mar Drugs. 2024 Dec 30;23(1):16. doi: 10.3390/md23010016.
5
Exploring the potential of naturally occurring antimicrobials for managing orthopedic-device-related infections.探索天然存在的抗菌剂在处理骨科器械相关感染方面的潜力。
J Bone Jt Infect. 2024 Oct 31;9(5):249-260. doi: 10.5194/jbji-9-249-2024. eCollection 2024.
6
Marine natural compounds as potential CBP bromodomain inhibitors for treating cancer: an in-silico approach using molecular docking, ADMET, molecular dynamics simulations and MM-PBSA binding free energy calculations.海洋天然化合物作为潜在的用于治疗癌症的CBP溴结构域抑制剂:一种使用分子对接、ADMET、分子动力学模拟和MM-PBSA结合自由能计算的计算机模拟方法
In Silico Pharmacol. 2024 Sep 18;12(2):85. doi: 10.1007/s40203-024-00258-5. eCollection 2024.
7
Rhabdastrellosides A and B: Two New Isomalabaricane Glycosides from the Marine Sponge , and Their Cytotoxic and Cytoprotective Effects.拉巴烷糖苷 A 和 B:来自海洋海绵的两种新型异马巴烷糖苷及其细胞毒性和细胞保护作用。
Mar Drugs. 2023 Oct 25;21(11):554. doi: 10.3390/md21110554.
8
Fascinating Furanosteroids and Their Pharmacological Profile.迷人的呋喃甾体及其药理学特性。
Molecules. 2023 Jul 26;28(15):5669. doi: 10.3390/molecules28155669.
9
Computational Approaches to Enzyme Inhibition by Marine Natural Products in the Search for New Drugs.计算方法在海洋天然产物抑制酶中的应用——寻找新药的途径。
Mar Drugs. 2023 Jan 30;21(2):100. doi: 10.3390/md21020100.
10
Total Synthesis of Terpenes and Their Biological Significance: A Critical Review.萜类化合物的全合成及其生物学意义:综述
Pharmaceuticals (Basel). 2022 Nov 11;15(11):1392. doi: 10.3390/ph15111392.
岩海绵内酯M与人IIA族磷脂酶A₂的结合模式:探索共价和非共价相互作用在抑制过程中的作用。
Chemistry. 2009;15(5):1155-63. doi: 10.1002/chem.200801512.
4
Effects of petrosaspongiolide R on the surface topology of bee venom PLA(2): a limited proteolysis and mass spectrometry analysis.岩海绵内酯R对蜂毒磷脂酶A2表面拓扑结构的影响:有限蛋白酶解和质谱分析
Bioorg Chem. 2009 Feb;37(1):6-10. doi: 10.1016/j.bioorg.2008.09.001. Epub 2008 Oct 21.
5
Rhabdastrellins A-F, isomalabaricane triterpenes from the marine sponge Rhabdastrella aff. distincta.横纹海绵素A - F,源自海洋海绵近似独特横纹海绵的异玛拉巴烷三萜类化合物。
J Nat Prod. 2008 Oct;71(10):1738-41. doi: 10.1021/np800324v. Epub 2008 Oct 1.
6
Aplysinoplides A-C, cytotoxic sesterterpenes from the marine sponge Aplysinopsis digitata.来自海洋海绵指状拟阿脑虫的细胞毒性倍半萜烯类化合物阿普里西诺普里德A - C。
J Nat Prod. 2008 Jun;71(6):1089-91. doi: 10.1021/np8001207. Epub 2008 May 8.
7
Induction of apoptosis accompanying with G(1) phase arrest and microtubule disassembly in human hepatoma cells by jaspolide B, a new isomalabaricane-type triterpene.贾斯泼内酯 B,一种新型异马陆烷型三萜,诱导人肝癌细胞凋亡伴随 G1 期阻滞和微管解聚。
Cancer Lett. 2008 Apr 8;262(1):114-22. doi: 10.1016/j.canlet.2007.11.039. Epub 2008 Jan 8.
8
Isolation and structures of erylosides from the Carribean sponge Erylus goffrilleri.从加勒比海绵Erylus goffrilleri中分离出的erylosides及其结构
J Nat Prod. 2007 Dec;70(12):1871-7. doi: 10.1021/np070319y. Epub 2007 Nov 16.
9
Rhabdastrellic acid-A inhibited PI3K/Akt pathway and induced apoptosis in human leukemia HL-60 cells.横纹海绵酸-A抑制人白血病HL-60细胞中的PI3K/Akt信号通路并诱导其凋亡。
Cell Biol Int. 2008 Jan;32(1):48-54. doi: 10.1016/j.cellbi.2007.08.009. Epub 2007 Sep 1.
10
Stellettins L and M, cytotoxic isomalabaricane-type triterpenes, and sterols from the marine sponge Stelletta tenuis.来自薄星骨海绵的细胞毒性异马拉巴烷型三萜类化合物——星骨海绵素L和M以及甾醇。
J Nat Prod. 2007 Jul;70(7):1114-7. doi: 10.1021/np070069l. Epub 2007 Jun 30.